A thorough QT/QTc study of multiple doses of tapentadol immediate release inhealthy subjects.

Trial Profile

A thorough QT/QTc study of multiple doses of tapentadol immediate release inhealthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Jan 2011

At a glance

  • Drugs Moxifloxacin; Tapentadol
  • Indications Back pain; Bacterial infections; Musculoskeletal pain; Pain; Postoperative pain
  • Focus Adverse reactions
  • Sponsors Grunenthal; Janssen Research & Development
  • Most Recent Events

    • 24 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top